1Ronco C,Haapio M,House AA,et al.Cardiorenal syndrome[J].J Am Coll Cardiol,2008,52(9):1527.
2Heywood JT.The cardiorenal syndrome:lessons from the ADHERE database and treatment options[J].Heart Fail Rev,2004,9(2):195.
3Adams KF Jr,Fonarow GC,Emerman CL,et al.ADHERE scientific advisory committee and investigators.Characteristics and outcomes of patients hospitalized for heart failure in the United States:rationale,design,and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)[J].Am Heart J,2005,149(2):209.
4Foley RN,Parfrey PS,Harnett JD,et al.Clinical and echocardiographic disease in patients starting end-stage renal disease therapy[J].Kidney Int,1995,47(2):186.
6Silverberg D,Wexler D,Blum M,et al.The association between congestive heart failure and chronic renal disease[J].Curr Opin Nephrol Hypertens,2004,13(2):163.
7Himanshu Sekhar Mahapatra,Robert Lalmalsawma,Narendra Pal Singh,et al.Cardiorenal syndrome[J].Iranian Journal of Kidney Diseases,2009,3(1):61.
8Santos RA,Simoes E,Silva AC,et al.Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas[J].Proc Nat Acad sci USA,2003,100(14):8258.
10Katoh M,Egashira K,Usui M,et al.Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats[J].Circ Res,1998,83(8):743.
